Health
Vertanical secures FDA breakthrough designation for pain drug
Vertanical secures FDA breakthrough designation for a cannabis-based pain drug, signaling a major shift in pharmaceutica…
Elena Marchetti·
6 articles
Vertanical secures FDA breakthrough designation for a cannabis-based pain drug, signaling a major shift in pharmaceutica…
Gland Pharma stock surged after USFDA approved its glaucoma drug on May 10, 2026, boosting access to affordable treatmen…
Odyssey Therapeutics climbs 11% after a $304 million US IPO, signaling strong investor confidence in its innovative ther…
President Trump signed an executive order on April 21, 2026, to accelerate psychedelic drug reviews by the FDA, signalin…
CVS Health announces four landmark drug treatments expected to change patient care this spring, signaling a pivotal mome…
Novartis strikes up to $2 billion deal for Excellergy, marking a major strategic move to boost its portfolio.